Day: January 19, 2026

Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat. More than 200 conditions are classified as rheumatic diseases, and they tend to affect the joints and connective tissues.